Tricuspid valve endocarditis presenting as multifocal cavitating pneumonia

Br J Cardiol 2024;31(4)doi:10.5837/bjc.2024.049 Leave a comment
Click any image to enlarge
Authors:
First published online 6th November 2024

A young man with multifocal cavitating pneumonia presented with early abscess formation secondary to Staphylococcus aureus bacteraemia treated with intravenous (IV) flucloxacillin. Further workup with transthoracic echocardiography revealed a large vegetation on the tricuspid valve with at least moderate tricuspid regurgitation; however, there were no peripheral stigmata of infective endocarditis. There was no history of intravenous drug use, but he had a history of administering frequent intramuscular recreational steroid injections. He also had a recent history of a loose tooth. In addition, there were multiple skin excoriations from scratching related to anxiety. Transoesophageal echocardiography confirmed two vegetations on the tricuspid valve, the largest measuring 21 mm with evidence of severe tricuspid regurgitation. The findings were discussed in the cardiac surgery multidisciplinary meeting and the consensus was for initial sterilisation with IV antibiotics followed by surgery.

Introduction

The tricuspid valve (TV) is involved in 90% of patients with right-sided endocarditis and is most common in people with intravenous drug use (IVDU). Septic pulmonary emboli occur in >50% of patients with TV involvement and manifests with various respiratory symptoms.1

Case report

A 38-year-old man presented with a prodrome of flu-like illness along with night sweats, pleuritic chest pain and cough for two weeks unresponsive to the usual first- and second-line oral antibiotics (amoxicillin 1 g 8 hourly for five days, and doxycycline 100 mg 12 hourly for five days, respectively). There was no history of illicit IVDU or any condition suggesting that he was immunocompromised; however, there was a history of administering frequent intramuscular recreational steroid injections. He also had a history of a loose tooth over the past two months. He had no peripheral stigmata of infective endocarditis. Skin examination revealed multiple excoriations on both forearms from scratching related to anxiety. Blood workup revealed raised inflammatory markers, including a C-reactive protein of 120 mg/L (normal: 0–5 mg/L). Chest X-ray (figure 1A) and computed tomography (figure 1B) findings were consistent with multifocal cavitating pneumonia with early abscess formation. Further assessment, including screening for HIV, tuberculosis and atypical infections, was negative. Blood cultures revealed a methicillin-sensitive Staphylococcus aureus bacteraemia for which he was started on intravenous (IV) flucloxacillin 2 g IV four times a day. His loose tooth may have been an additional source of his bacteraemia. Further workup with transthoracic echocardiography for S. aureus bacteraemia demonstrated a large, partially mobile echodensity on the TV with at least moderate tricuspid regurgitation (TR). Transoesophageal echocardiography confirmed two vegetations on the TV (figure 2A), the largest measuring 21 mm, along with evidence of severe TR (figure 2B). The findings were discussed in the cardiac surgery multidisciplinary meeting and the consensus was for initial sterilisation with IV flucloxacillin followed by excision of the vegetation with or without TV repair.2

Baral - Figure 1. A. Chest X-ray demonstrating multifocal pneumonia. B. Computed tomography of the chest (axial view) demonstrating multifocal cavitating pneumonia
Figure 1. A. Chest X-ray demonstrating multifocal pneumonia. B. Computed tomography of the chest (axial view) demonstrating multifocal cavitating pneumonia
Baral - Figure 2. A. Transoesophageal echocardiogram demonstrating two vegetations in the tricuspid valve. B. Colour Doppler analysis during transoesophageal echocardiogram demonstrating severe regurgitation through the tricuspid valve
Figure 2. A. Transoesophageal echocardiogram demonstrating two vegetations in the tricuspid valve. B. Colour Doppler analysis during transoesophageal echocardiogram demonstrating severe regurgitation through the tricuspid valve

Discussion

This case reinforces the importance of detailed work-up, including an echocardiography, in patients with multifocal cavitary pneumonia and also the need for echocardiography in S. aureus bacteraemia without an apparent source.3 All patients with TV endocarditis need treatment with IV antibiotics along with a multidisciplinary discussion for surgical assessment, especially in those with persistent bacteraemia after at least one week of appropriate antibiotic therapy, large TV vegetations (>20 mm), recurrent septic pulmonary emboli, involvement of left-sided structures and right-sided heart failure secondary to severe TR unresponsive to diuretics.4

Key messages

  • In right-sided endocarditis, the tricuspid valve is involved in 90% of patients and is most common in people with intravenous drug use
  • Septic pulmonary emboli occur in >50% of patients with tricuspid valve involvement and manifests with various respiratory symptoms and signs, such as multifocal cavitatory pneumonia seen in this case
  • In patients with an unidentified source of bacteraemia, a detailed workup including echocardiography is essential to identify the underlying pathogen and appropriate intravenous treatment commenced while considering surgical interventions

Conflicts of interest

None declared.

Funding

None.

Statement of consent

Written consent was granted by the patient for publication of this case report.

References

1. Yuan SM. Right-sided infective endocarditis: recent epidemiologic changes. Int J Clin Exp Med 2014;7:199–218. [Epub online ahead of print]

2. Hussain ST, Witten J, Shrestha NK, Blackstone EH, Pettersson GB. Tricuspid valve endocarditis. Ann Cardiothorac Surg 2017;6:255–61. https://doi.org/10.21037/acs.2017.03.09

3. Abraham L, Bamberger DM. Staphylococcus aureus bacteremia: contemporary management. Mo Med 2020;117:341–5.

4. Delgado V, Ajmone Marsan N, de Waha S et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023;44:3948–4042. https://doi.org/10.1093/eurheartj/ehad193

THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT